150 related articles for article (PubMed ID: 9811164)
1. Efflux transport of tolbutamide across the blood-brain barrier.
Takanaga H; Murakami H; Koyabu N; Matsuo H; Naito M; Tsuruo T; Sawada Y
J Pharm Pharmacol; 1998 Sep; 50(9):1027-33. PubMed ID: 9811164
[TBL] [Abstract][Full Text] [Related]
2. Efflux of a suppressive neurotransmitter, GABA, across the blood-brain barrier.
Kakee A; Takanaga H; Terasaki T; Naito M; Tsuruo T; Sugiyama Y
J Neurochem; 2001 Oct; 79(1):110-8. PubMed ID: 11595763
[TBL] [Abstract][Full Text] [Related]
3. Tolbutamide uptake via pH- and membrane-potential-dependent transport mechanism in mouse brain capillary endothelial cell line.
Koyabu N; Takanaga H; Matsuo H; Naito M; Tsuruo T; Ohtani H; Sawada Y
Drug Metab Pharmacokinet; 2004 Aug; 19(4):270-9. PubMed ID: 15499195
[TBL] [Abstract][Full Text] [Related]
4. Blood-brain barrier is involved in the efflux transport of a neuroactive steroid, dehydroepiandrosterone sulfate, via organic anion transporting polypeptide 2.
Asaba H; Hosoya K; Takanaga H; Ohtsuki S; Tamura E; Takizawa T; Terasaki T
J Neurochem; 2000 Nov; 75(5):1907-16. PubMed ID: 11032880
[TBL] [Abstract][Full Text] [Related]
5. Effect of bioflavonoids on vincristine transport across blood-brain barrier.
Mitsunaga Y; Takanaga H; Matsuo H; Naito M; Tsuruo T; Ohtani H; Sawada Y
Eur J Pharmacol; 2000 May; 395(3):193-201. PubMed ID: 10812049
[TBL] [Abstract][Full Text] [Related]
6. Brain-to-blood efflux transport of estrone-3-sulfate at the blood-brain barrier in rats.
Hosoya K; Asaba H; Terasaki T
Life Sci; 2000 Oct; 67(22):2699-711. PubMed ID: 11105986
[TBL] [Abstract][Full Text] [Related]
7. In-vivo and in-vitro evidence of a carrier-mediated efflux transport system for oestrone-3-sulphate across the blood-cerebrospinal fluid barrier.
Kitazawa T; Hosoya K; Takahashi T; Sugiyama Y; Terasaki T
J Pharm Pharmacol; 2000 Mar; 52(3):281-8. PubMed ID: 10757415
[TBL] [Abstract][Full Text] [Related]
8. High-affinity efflux transport system for glutathione conjugates on the luminal membrane of a mouse brain capillary endothelial cell line (MBEC4).
Homma M; Suzuki H; Kusuhara H; Naito M; Tsuruo T; Sugiyama Y
J Pharmacol Exp Ther; 1999 Jan; 288(1):198-203. PubMed ID: 9862771
[TBL] [Abstract][Full Text] [Related]
9. Influx and efflux transport of H1-antagonist epinastine across the blood-brain barrier.
Ishiguro N; Nozawa T; Tsujihata A; Saito A; Kishimoto W; Yokoyama K; Yotsumoto T; Sakai K; Igarashi T; Tamai I
Drug Metab Dispos; 2004 May; 32(5):519-24. PubMed ID: 15100174
[TBL] [Abstract][Full Text] [Related]
10. Efflux transport of a new quinolone antibacterial agent, HSR-903, across the blood-brain barrier.
Murata M; Tamai I; Kato H; Nagata O; Tsuji A
J Pharmacol Exp Ther; 1999 Jul; 290(1):51-7. PubMed ID: 10381759
[TBL] [Abstract][Full Text] [Related]
11. Possible involvement of cationic-drug sensitive transport systems in the blood-to-brain influx and brain-to-blood efflux of amantadine across the blood-brain barrier.
Suzuki T; Fukami T; Tomono K
Biopharm Drug Dispos; 2015 Mar; 36(2):126-37. PubMed ID: 25410756
[TBL] [Abstract][Full Text] [Related]
12. Transport of cyclosporin A across the brain capillary endothelial cell monolayer by P-glycoprotein.
Shirai A; Naito M; Tatsuta T; Dong J; Hanaoka K; Mikami K; Oh-hara T; Tsuruo T
Biochim Biophys Acta; 1994 Jul; 1222(3):400-4. PubMed ID: 7913624
[TBL] [Abstract][Full Text] [Related]
13. Contribution of P-glycoprotein to efflux of ramosetron, a 5-HT3 receptor antagonist, across the blood-brain barrier.
Yamamoto C; Murakami H; Koyabu N; Takanaga H; Matsuo H; Uchiumi T; Kuwano M; Naito M; Tsuruo T; Ohtani H; Sawada Y
J Pharm Pharmacol; 2002 Aug; 54(8):1055-63. PubMed ID: 12195819
[TBL] [Abstract][Full Text] [Related]
14. Na(+)- and Cl(-)-dependent transport of taurine at the blood-brain barrier.
Tamai I; Senmaru M; Terasaki T; Tsuji A
Biochem Pharmacol; 1995 Nov; 50(11):1783-93. PubMed ID: 8615856
[TBL] [Abstract][Full Text] [Related]
15. P-glycoprotein mediates brain-to-blood efflux transport of buprenorphine across the blood-brain barrier.
Suzuki T; Zaima C; Moriki Y; Fukami T; Tomono K
J Drug Target; 2007 Jan; 15(1):67-74. PubMed ID: 17365275
[TBL] [Abstract][Full Text] [Related]
16. In vivo evidence for carrier-mediated efflux transport of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine across the blood-brain barrier via a probenecid-sensitive transport system.
Takasawa K; Terasaki T; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 1997 Apr; 281(1):369-75. PubMed ID: 9103519
[TBL] [Abstract][Full Text] [Related]
17. Role of P-glycoprotein in limiting the brain penetration of glabridin, an active isoflavan from the root of Glycyrrhiza glabra.
Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Yu XQ; Chowbay B; Wen JY; Duan W; Chan E; Li XT; Cao J; Li CG; Xue CC; Zhou SF
Pharm Res; 2007 Sep; 24(9):1668-90. PubMed ID: 17551811
[TBL] [Abstract][Full Text] [Related]
18. GSH transport in human cerebrovascular endothelial cells and human astrocytes: evidence for luminal localization of Na+-dependent GSH transport in HCEC.
Kannan R; Chakrabarti R; Tang D; Kim KJ; Kaplowitz N
Brain Res; 2000 Jan; 852(2):374-82. PubMed ID: 10678765
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of P-glycoprotein: rapid assessment of its implication in blood-brain barrier integrity and drug transport to the brain by an in vitro model of the blood-brain barrier.
Fenart L; Buée-Scherrer V; Descamps L; Duhem C; Poullain MG; Cecchelli R; Dehouck MP
Pharm Res; 1998 Jul; 15(7):993-1000. PubMed ID: 9688050
[TBL] [Abstract][Full Text] [Related]
20. Prediction of in vivo drug-drug interactions between tolbutamide and various sulfonamides in humans based on in vitro experiments.
Komatsu K; Ito K; Nakajima Y; Kanamitsu Si; Imaoka S; Funae Y; Green CE; Tyson CA; Shimada N; Sugiyama Y
Drug Metab Dispos; 2000 Apr; 28(4):475-81. PubMed ID: 10725317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
